Interconversion of D-ribose 5-phosphate and D-ribulose 5-phosphate is an important step in the pentose phosphate pathway. Two unrelated enzymes with D-ribose-5-phosphate isomerase activity were first identified in Escherichia coli, RpiA and RpiB. In this organism, the essential 5-carbon sugars were thought to be processed by RpiA, while the primary role of RpiB was suggested instead to be interconversion of the rare 6-carbon sugars, D-allose 6-phosphate and D-allulose 6-phosphate. In Mycobacterium tuberculosis, where only an RpiB is found, the 5-carbon sugars are believed to be the enzyme's primary substrates. Here we present kinetic studies examining the D-allose-6-phosphate isomerase activity of the RpiBs from these two organisms, and show that only the E. coli Keywords: Ribose-5-phosphate isomerase; allose-6-phosphate isomerase; rare sugar; Xray crystallography; Rv2465c. 
Introduction
D-Ribose-5-phosphate isomerase (Rpi, EC 5.3.1.6) is one of the major enzymes in the pentose phosphate pathway, where it catalyses the interconversion of D-ribose 5- phosphate (R5P) and D-ribulose 5-phosphate (Ru5P). Two forms of this isomerase with no amino acid sequence similarity have been characterized in Escherichia coli, RpiA and RpiB.
1,2 EcRpiB is not important under most conditions, both because it is not constitutively expressed, and because its rate of catalysis is much slower. It has been
proposed that the principal role of this enzyme is instead to catalyze the isomerization of two 6-carbon sugars, D-allose 6-phosphate (All6P) and D-allulose 6-phosphate (Allu6P).
The physiological significance has not yet been demonstrated but it is known that
EcRpiB is associated with an operon that is necessary for survival when D-allose is the sole carbon source. 3, 4 The operon encodes a repressor (alsR), three ABC transporter proteins (alsBAC), a putative D-allose-6-phosphate 3-epimerase (alsE) and a D-allokinase (alsK). The structure of the periplasmic D-allose binding protein, AlsB, solved in complex with D-allose supports the idea that the transport system specifically recognizes that sugar. 5 Activity measurements with AlsK have further shown that D-allose is phosphorylated with a k cat of 17 s -1 and a K m of 0.3 mM, consistent with values obtained for similar enzymes when processing their cognate sugars. 6 The rpiB gene lies just upstream of this operon and is also regulated by the AlsR repressor, also known as RpiR.
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5 into metabolism by converting it to D-fructose 6-phosphate. In vitro experiments have shown that L-rhamnose isomerase from Pseudomonas stutzeri and RpiB from
Clostridium thermocellum can convert D-allulose into D-allose. 11, 12 These studies were aimed at finding a cost-efficient means of producing D-allose, due to its reported medical applications. 13 We do not know of any evidence that the organisms themselves utilize the enzymes in the metabolism of D-allose.
Like many bacteria, Mycobacterium tuberculosis lacks an RpiA sequence, having only an RpiB gene; in the genome, the sequence coding for MtRpiB has been annotated as rv2465c. 14 It is presumed that the major role of MtRpiB lies within the pentose phosphate pathway, since ribose is of central importance in any living organism. We have previously solved the three dimensional structure of MtRpiB (PDB entry code 1USL) 15 and demonstrated that it catalyzes the R5P isomerization with kinetic constants very similar to those reported for EcRpiB. 16 Comparison with the EcRpiB structure (1NN4) 16 indicated that while the two proteins are very similar, some key active site residues are different. X-ray structures of MtRpiB in complex with two substrate analogues (2BES and 2BET) 17 allowed us to assign roles for most of the active site residues in the 5-carbon sugar reaction (Fig. 1 ). Kinetic studies with a compound designed to mimic the enediolate intermediate of the proposed All6P reaction, 5-deoxy-5-phospho-Dribonohydroxamate (5PRH), have shown that a 6-carbon sugar analogue can inhibit the R5P isomerization in MtRpiB with a K i of 0.4 mM. 18 Here we present kinetic studies showing that EcRpiB can catalyze the conversion of All6P to Allu6P with reasonable efficiency, but MtRpiB cannot. All6P instead acts as an inhibitor of MtRpiB in the isomerization of R5P. X-ray structures of MtRpiB cocrystallised with All6P and 5PRH reveal differences in the active sites that explain the kinetic results. Two other structures co-crystallized with R5P, an EcRpiB H99N mutant, and wild type MtRpiB, shed additional light on the reaction mechanism of RpiBs.
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Results

Activity of EcRpiB and MtRpiB
EcRpiB and MtRpiB were tested for activity on R5P and All6P. Confirming earlier results, 15, 16 the two enzymes have very similar k cat and K m for R5P. Allu6P production was followed using a novel assay based on the thiobarbituric acid (TBA) colorimetric method previously designed for monitoring D-fructose 6-phosphate production. 19 Fig . 2a-d shows the experimental data, and Table 1 summarizes the catalytic constants derived.
EcRpiB has a lower K m for All6P than for R5P, although the latter is processed at a 10-fold faster rate. The calculated k cat /K m differs only 4-fold when R5P and All6P are compared. MtRpiB is less efficient at isomerizing All6P, having a much higher K m , as well as a drastically lower k cat . Further, All6P acts as an inhibitor of the reaction when R5P is used as substrate, with a measured IC 50 of 2 mM; Allu6P is a slightly worse inhibitor with an IC 50 of 6.3 mM (Fig. 2e,f) .
MtRpiB Complex Structures
X-ray data were collected for wild type MtRpiB co-crystallized with the substrate R5P, and two inhibitors, 5PRH and All6P. The three models were refined to resolutions of 2 Å or better (Table 2) . Each asymmetric unit contained five molecules, organised as two complete dimers plus one lone subunit that forms a dimer by virtue of a 2-fold crystallographic symmetry axis. In all cases the protein could be traced from residue 2 or 3 to residue 158 or 160, out of the 172 residues in the sequence. The N-terminal His-tag was not seen in the electron density.
The two active sites of an MtRpiB dimer are located in clefts between the two subunits, with components drawn from both molecules; with the exception of Arg113, interactions with residue numbers less than 100 arise from the A molecule, and the others from the B molecule. A cartoon representation is shown in Fig. 3a . The electron density
in the active site was well defined and showed that the ligand was bound in all five molecules of the asymmetric unit in all three structures.
In the R5P complex (Fig. 3b) , little or no furanose form of R5P was present; the electron density was most consistent with a mixture of the linear forms of both R5P and
Ru5P. This observation is in agreement with the equilibrium constant value of ~0.33
reported for the isomerization of R5P. 20 At 1.65 Å resolution, it is not possible to investigate the relative proportions in detail, and both R5P and Ru5P were included in the refinement at occupancies of 0.5, which resulted in well-behaved maps, and temperature factors for the ligands that were similar to those of the surrounding protein (15-20 Å 2 ).
The manner in which R5P and Ru5P bind in the active site of MtRpiB is highly similar to the binding of the substrate analogue inhibitor 4-deoxy-4-phospho-Derythronohydroxamic acid, 4PEH (Fig. 1) . 17 The two structures superimpose with an r.m.s. difference of 0.2 Å when all C α atoms of the 5 protein molecules of the asymmetric unit are aligned. The active site residues are positioned in the same way, except in the immediate neighbourhood of the catalytic base Glu75, where the carboxylate moiety assumes slightly different angles in the two models (Fig. 3b) .
The density seen in the active sites when MtRpiB was co-crystallized with 5PRH
does not account for the whole ligand (Fig. 4a) , and we concluded that the compound had been hydrolyzed to produce another good inhibitor, 5-deoxy-5-phospho-D-ribonate (5PRA, Fig. 1 ). 5PRA binds with the phosphate group in the same position as for the R5P, with interactions to residues Arg113 and His12 in the A molecule, and Arg137 and Arg141 in the B molecule. The proposed ring-opening catalyst, His102-B, 17 interacts with O4, while O3 makes a hydrogen bond with Asp11-A; both interactions are seen in the other structures. Differences in binding occur at the top of the ligand, where O2 of 5PRA lies in the same position as C1 of the substrate and hydrogen bonds to Glu75-A, C1 of 5PRA points in the same direction as O2 of the substrate, and the carboxylate moiety interacts with Glu75 and backbone nitrogen atoms of the oxyanion hole (Fig. 4a) .
The interactions of O2 and one of the carboxylate oxygens of 5PRA to the two carboxylate oxygens of Glu75-A involve short, tight hydrogen bonds of 2.7 and 2.4 Å, respectively. This implies that at least one of the partners in each case is protonated.
These crystals were grown in the presence of 0.2 M Li 2 SO 4 , and two molecules of SO 4 2- are also found in the electron density. Neither ion appears to have an important role in the structure, although they may enhance dimer and crystallographic contacts.
In the MtRpiB/All6P complex, the density in the active site (Fig. 4b) O1, observed as the α-anomer, interacts only with His102. Tyr46-A, a conserved residue in all RpiBs, lies with its ring almost parallel to the sugar ring, and ~4 Å away (Fig. 4b ).
Favourable stacking interactions between the aromatic side chain of the protein and the nonpolar surface of the sugar ring are expected.
The EcRpiB-H99N mutant
An EcRpiB His99 to Asn mutant constructed by site-directed mutagenesis exhibited a K m for R5P of 0.8 mM, similar to the wild type enzyme, but k cat was reduced to 2 s -1 , as
to be traced from residue 1 (not including the 6-His tag) to 146 or 147 in all 6 molecules (out of 149 residues in total). Data collection and refinement statistics are summarized in Table 2 .
In each active site, density strongly suggests a mixture of α-and β-furanose forms of R5P, together with linear R5P or Ru5P. Interestingly, the two active sites in each dimer have different species bound. One active site (molecules A, D and F) has primarily the linear form and very little furanose (Fig. 5a ). The other subunit of each dimer (molecules B, C and E) has mostly furanose sugar, but with a considerable fraction of the linear form (Fig. 5b) . The distinctions were even clearer when density from the equivalent active sites was averaged. The differences can be traced back to crystal packing and involve different conformations of the His17 side chain located on the surface of the first helix. In the A, D and F molecules, the histidine points toward Phe13-A, possibly shielding it from water. In the B, C and E molecules, this histidine points straight out toward a symmetry related molecule's Arg133 (Fig. 5c,d ). This arginine is involved in binding the phosphate group of the ligand; in the active sites that have the His17/Arg133 interaction, the predominant form of the substrate is the furanose. Other residues in the same helix, glutamates 18 and 25, could form salt links to Arg40 of the neighboring active site, although the density for this arginine is not well defined.
Presumably it is interacting with the phosphate of the ligand some of the time, as well as with the neighboring glutamates.
In the β-furanose form of R5P, O1 interacts with Asn100-A and is close to one of the carbon atoms of Tyr43-B (3.3 Å; equivalent to MtRpiB Tyr46). The hydroxyl group is ~2.9 Å from a water molecule that is within hydrogen bonding distance of His134 and O4. O4 has an additional hydrogen bond to Asn99-A. O3 interacts with the backbone nitrogen of residue 67-B and the carboxylate of Asp9-B, while O2 is next to Cys66-B. An α-furanose has the same interactions apart from O1, which in this case is ~3.4 Å from Asn99.
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Comparisons of available RpiB structures
Comparison of the mutant EcRpiB AB-dimer to the original wild type EcRpiB AD-dimer
(PDB entry 1NN4) shows that the r.m.s. difference is only 0.3 Å for 287 C α atoms using a cutoff of 0.8 Å. The small changes include several residues with alternative side chain conformations. The most striking difference is the conformation of Thr68, which now has its OH group oriented in the same direction as that of the equivalent serine residue in
MtRpiB.
We believe this to represent a minor error in the original structure.
The various MtRpiB models are also very similar, with r.m.s. differences between 0.15 and 0.36 Å when comparing the AB dimers. As mentioned previously the MtRpiB with R5P is very similar to PDB entry 2BES, the complex of the same enzyme with 4PEH. SpRpiB does not align as well to the two RpiBs studied here, and the sequences have low identity. However, the general topology is very similar, with the main differences in the loops connecting the secondary structural elements; the C-terminal end also has additional α-helices that extend the fold of the subunit.
Superpositioning of the
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Comparisons of RpiB active sites
When EcRpiB and MtRpiB are superimposed, the transformation brings the C α atoms of the N-terminal end of the helix at the bottom of the active site cleft very close together.
The Leu98/Leu95 to take on different conformations. In EcRpiB, the leucine is forced down toward Asn99 (the mutated residue), which in turn pushes His134 down (Fig. 6b) . In all
MtRpiB structures presented here, Arg113-A interacts with the phosphate group; in the original apo structure (PDB entry 1USL), this residue had two different conformations, one pointing toward the phosphate and one pointing out into solution. In EcRpiB, the equivalent Arg110 is not involved in phosphate binding (Fig. 6b) . Although the phosphate group interacts with a similar set of positively charged residues, its density places this part of a bound ligand slightly further away from the catalytic groups in
EcRpiB when compared to the situation in all of the MtRpiB complexes.
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In TmRpiB the active site residues align reasonably well with those of the other two RpiBs. The active site cysteine, which aligns perfectly with Cys66 of EcRpiB, was found to be oxidized, and so was modeled as a cysteine sulfonic acid. 21 This causes Arg136 is slightly further away from the location where the phosphate would be expected to bind.
The residues lining the active site of SpRpiB are more variable. However, the C α atoms at the N-terminal end of the helix in the active site (with the sequence CGTGVG), which also include the catalytic cysteine and threonine residues, align perfectly. Asn100
and Tyr43 are also conserved. Asp9 of the E. coli enzyme is replaced by a glutamate in 
Discussion
Aggregation state
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In the first EcRpiB apo structure, 16 the enzyme was found as a tetramer, an observation that was also supported by dynamic light scattering experiments. However, the enzyme had previously been found to behave as a dimer during size exclusion chromatography.
1,2
The tetramer seen in the crystal was thought to be partly due to the long N-terminal Histag, which would promote dimer-dimer interactions. The high protein concentrations used in crystallization and light scattering experiments would also be expected to favor tetramer formation. In the present study, a construct with a shorter N-terminal His-tag was used; the protein still behaved as a dimer during size exclusion chromatography.
However, the dimer-dimer interactions that build the tetramer are still observed in the new crystal form, resulting from both non-crystallographic and crystallographic symmetry. We conclude that both dimer and tetramer are likely to be relevant species for this enzyme in solution.
Ring opening
The present study with the MtRpiB-R5P complex demonstrates that the linear substrate or product does indeed bind in the same manner as the high-energy intermediate analogue studied earlier, 4PEH. 17 It was considered likely that RpiB is involved in opening the R5P furanose ring, since only 0.1% of the sugar is in the linear form in solution. 23 We previously proposed that His102 of MtRpiB catalyzes this opening by donating a proton to O4 of the furanose. The EcRpiB-H99N mutant presented here is a conservative substitution of the equivalent histidine. Consistent with the proposed role, the mutant protein had a K m similar to the wild type, but a 26-fold lower k cat (Table 1) . A comparable mutation in Trypanosoma cruzi RpiB, where His102 was changed to alanine, resulted in an enzyme with K m s for both R5P and Ru5P similar to the wild type enzyme. 24 The k cat was 10-fold lower in the forward reaction, whereas k cat was almost the same for the reverse reaction. This implies that the mutant enzymes have no difficulty in performing the isomerization when they are given a linear substrate, but that they are slower if most
of the substrate is in the ring form, as they must wait for an open R5P molecule to diffuse into the active site.
These conclusions are supported by comparison of the structures of wild type
MtRpiB and EcRpiB-H99N co-crystallized with R5P. In the wild type protein, only linear forms of the sugar were observed in the active site (Fig. 4a) , while in the mutant protein the observed density corresponds to α-and/or β-ribofuranose 5-phosphate as well as linear molecules (Fig. 5a,b) . The docking of either furanose in the active-site density of EcRpiB-H99N places O4 of the sugar in close proximity to Asn99. In MtRpiB, O4 of both linear sugars lies next to the equivalent His102 (Fig. 6b) . An alternate scenario is that the water could donate a proton to O4, and His99/102 accept that from O1.
Substrate specificity
The kinetic data show that EcRpiB is a much more effective catalyst than MtRpiB of the All6P-Allu6P interconversion (Table 1) . Indeed, the 6-carbon sugar is an inhibitor of MtRpiB when R5P is substrate. Our numerous attempts to obtain the structure of a complex of EcRpiB with All6P resulted only in uninterpretable electron density in the active site. Presumably a mixture of sugar forms is present, similar to the results (Fig. 4b) . The preference is explained by the fact that the α-anomer has one additional hydrogen bond to protein (involving His102) compared with a docked β-anomer. The ring oxygen (O5) of All6P assumes the position expected for the ring oxygen (O4) of the substrate R5P. O5 also forms a hydrogen bond to a water molecule interacting with His138, although the distance to His102 is greater than in the EcRpiB-H99N structure. Thus, we conclude that His102 and the water molecule near His138
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should be able to catalyze opening of the All6P pyranose ring. The equivalent groups will have the same roles in EcRpiB. In MtRpiB, the problems seem to arise at the next step.
Once opened, the sugar phosphate is too long to fit into the MtRpiB active site with productive interactions to Glu75 and Ser71. In the All6P structure, Glu75 is already forced up, away from the ligand, incorrectly situated to catalyze the isomerization (Fig.   4b ). We earlier proposed that the long, flexible arginine and histidine side chains that interact with the phosphate moiety of a substrate/inhibitor could swing further away from the catalytic residues, and so accommodate the longer 6-carbon substrate. 18 We see no evidence from the combined structures that such is the case. However, differences that appear relevant are observed in the structures of EcRpiB and MtRpiB, which can be traced back to two residue substitutions. A Tyr91/Gln94 (Ec/Mt) substitution allows
Leu95 of EcRpiB to take on a different conformation compared to the equivalent Leu98 in MtRpiB, bringing it down toward His99. This results in a shift of the two histidines (99 and 134) even further down toward the active site opening compared to their equivalents in MtRpiB (Fig. 6b) . This shift places them in a good position for opening a furanose or pyranose ring placed further along the active site. The second change involves Arg40 in EcRpiB, which is replaced by Asp43 in MtRpiB. This residue is located in a loop at the
17 very entrance to the active site (Fig. 6 ). In MtRpiB, the aspartic acid consistently points out into the surrounding solution, repelled by the overall negative charge of the phosphate. In the available EcRpiB structures, Arg40 frequently has poorly resolved density, although when it is ordered it is seen to bind the phosphate group. Minor differences between EcRpiB and MtRpiB include slight shifts in the phosphate-binding residues His10/His12 and Arg133/Arg137, which might make them better adapted to binding a phosphate molecule slightly farther away from the catalytic residues. However, these movements are less clearly linked to an amino acid substitution and may be simply due to natural flexibility in these residues.
Attempts to produce a structure of EcRpiB bound to 5PRH, a compound designed phosphoglucose isomerase. 25 It would appear that MtRpiB selectively binds the shorter R5P-like molecule (Fig. 4a) , in preference to the original All6P-like compound.
The isomerization of All6P and Allu6P in EcRpiB is thought to proceed in much the same manner as the isomerization of the 5-carbon sugar phosphate. The ring will presumably be opened by His99 and the water molecule. Once opened, the linear substrate will bind with its top part in the same orientation as observed for R5P in the intermedia is mainly associated with waste water although it is found in humans with gastrointestinal disorders. H. somnus can cause disease in humans and cattle; it inhabits
19 mucous membranes and is found in the blood stream. As E. coli resides in the gut, it seems possible that all three of these organisms are adapted to utilizing allose that accumulates through mammals' inability to metabolize the sugar. By virtue of a highaffinity transport system, the organism can accumulate the sugar, even when it is present at very low concentrations in the media. Links to pathogenicity provide for tempting speculation, but the bias of the currently available genome data toward pathogens suggests that this idea must be treated with caution.
Experimental Procedures Protein cloning, production and purification
EcRpiB was cloned into the pBAD/TOPO™ vector (Invitrogen) using the pCRT7/TOPO™ construct previously described 16 EcRpiB was purified in much the same manner as MtRpiB, as previously described. 15 Differences from the original protocol include cell lysis at 2 kBar using a cell The MtRpiB protein was cloned, over-expressed and purified as described previously 15 with the addition of a final purification step by size exclusion chromatography, in a buffer containing 20 mM Tris-HCl (pH 8.3), 150 mM NaCl, 10%
glycerol, 10 mM β-mercaptoethanol, 0.1 mM EDTA. The protein was concentrated to 7.5 -12 mg/mL during which the NaCl concentration in the buffer was decreased to 35 mM.
Kinetic assays
A spectrophotometic assay described previously, 20 in which the production of Ru5P is monitored as a change in absorbance at 290 nm, was used to characterize the EcRpiB-H99N mutant and both wild type Rpis. Kinetic constants were estimated from linear regression using Hanes-Woolf plots.
A spectrophotometric assay involving TBA was developed to test the conversion of All6P to Allu6P. The method 26, 27 was developed recently in one of our laboratories for the detection and quantification of D-fructose 6-phosphate. 19 We found that TBA reacts similarly with Allu6P 28 which, following dehydration and dephosphorylation in the presence of hydrogen chloride, gives rise to 5-hydroxymethylfurfural, which in turn reacts with TBA to yield the characteristic yellow adduct. The adduct absorbs strongly at 438 nm (ε = 27800 ± 100 M -1 cm -1 ). Under the same conditions, All6P 29 produced a TBA adduct with an extinction coefficient of 690, ~40 times smaller than that for Allu6P.
Therefore, a blank without enzyme was included to correct for the absorbance due to All6P. Typically, the assay mixture contained 50 mM Tris-HCl (pH 7.5), 0.8 to 8 mM interface. 32 Information related to data collection is presented in Table 2 .
EcRpiB-H99N was solved by molecular replacement with AMoRe 33 using the functional dimer of the original EcRpiB structure (PDB code 1NN4 with water molecules and histidine tag removed) as a search model. MtRpiB space group dimensions were similar enough for the five molecules in the original structure (PDB code 1USL with the water and phosphate ligands removed) to be placed by rigid body refinement in
Refmac5. 34 The models were then subjected to restrained refinement, and the resulting maps inspected for bound ligand density. Water molecules were placed after cycling with ARP/wARP. 35 R5P and 5PRA ligands of MtRpiB were placed with the ARP/wARP ligand tool 36 while others were placed manually in O. 37 Rounds of rebuilding and refinement resulted in the final models described in Table 2 .
Structural analysis, sequence and structural comparisons
Structures were compared using the lsq options in the graphics program O. 37 Similar sequences were identified using BLAST 22 and obtained from GenBank. 39 Figures were prepared with O and OPLOT, 40 Molray, 41 , MacPymol, 42 and ChemDraw (CambridgeSoft Corp).
Protein Data Bank accession
Atomic coordinates and structure factor data have been deposited in the Protein Data Bank 38 with entry codes 2VVP, 2VVQ, 2VVO, and 2VVR for MtRpiB/R5P-Ru5P, 
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